Detalhe da pesquisa
1.
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor.
Blood
; 143(20): 2059-2072, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38437498
2.
Phospholipid metabolic adaptation promotes survival of IDH2 mutant acute myeloid leukemia cells.
Cancer Sci
; 115(1): 197-210, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37882467
3.
Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome.
Cancer
; 130(11): 1964-1971, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340331
4.
Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2.
Blood
; 139(6): 907-921, 2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34601571
5.
Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms.
Blood
; 140(16): 1753-1763, 2022 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35512188
6.
Outcomes and genetic dynamics of acute myeloid leukemia at first relapse.
Haematologica
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38695144
7.
Seasonal and diurnal variations in soil respiration rates at a treeline ecotone and a lower distribution limit of subalpine forests.
J Plant Res
; 137(2): 179-190, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244125
8.
Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia.
Br J Haematol
; 203(4): 581-592, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608562
9.
Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia.
Blood
; 138(18): 1733-1739, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115096
10.
Technologies for whole-cell modeling: Genome-wide reconstruction of a cell in silico.
Dev Growth Differ
; 65(9): 554-564, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856476
11.
Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2).
Haematologica
; 108(9): 2331-2342, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951163
12.
The discovery of 3,3-dimethyl-1,2,3,4-tetrahydroquinoxaline-1-carboxamides as AMPD2 inhibitors with a novel mechanism of action.
Bioorg Med Chem Lett
; 80: 129110, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36563792
13.
Hypoxia enhances motility and EMT through the Na+/H+ exchanger NHE-1 in MDA-MB-231 breast cancer cells.
Exp Cell Res
; 412(1): 113006, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34979106
14.
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer.
Nature
; 542(7641): 362-366, 2017 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28178232
15.
Brain-Derived Major Glycoproteins Are Possible Biomarkers for Altered Metabolism of Cerebrospinal Fluid in Neurological Diseases.
Int J Mol Sci
; 24(7)2023 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37047057
16.
Ibrutinib and Venetoclax for First-Line Treatment of CLL.
N Engl J Med
; 380(22): 2095-2103, 2019 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31141631
17.
Mechanistic basis and efficacy of targeting the ß-catenin-TCF7L2-JMJD6-c-Myc axis to overcome resistance to BET inhibitors.
Blood
; 135(15): 1255-1269, 2020 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32068780
18.
Statistical tests for intra-tumour clonal co-occurrence and exclusivity.
PLoS Comput Biol
; 17(12): e1009036, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910733
19.
Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patients.
Am J Hematol
; 97(11): 1427-1434, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36053747
20.
Low-dose dasatinib 50 mg/day versus standard-dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis.
Am J Hematol
; 97(11): 1413-1418, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054032